What are the risk factors for in-hospital death and complications of COVID-19 in people with diabetes? 

Guest Author: Dr. Cyaandi R. Dove, D.P.M
A recent trial showed a significant reduction in wound area by 73.1% with Single Use Negative Pressure Wound Therapy System (sNPWT). 

Advances in diabetes technology and treatment over the past decade have failed to yield desired glycemic outcomes in many patients with T2DM.

Maintaining a regular pancreatic fat content could reduce the risk of metabolic diseases like type 2 diabetes.

$327 billion are spent annually for the treatment and management of diabetes.

Numerous complications associated with diabetes, including the risk of death, begin at the pre-diabetic stage.

Findings from a recently published meta-analysis of patients with pre-diabetes, with and without ASCVD, suggest an increased risk for premature death and cardiovascular events.

The EarlyBird study investigated how to predict future pre-diabetes and type 2 diabetes in children. Years of research have shown us that there are many factors that predispose patients to type 2 diabetes. However, researchers at the University of Plymouth, in collaboration with Nestlé Institute of Health Sciences, monitored children …

The FDA has given a Fast Track Designation to accelerate study of Farxiga’s effect on reduction in mortality and heart failure after a heart attack.

Type 2 diabetes damages brain regions that govern memory, movement, and visual processing.